Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study

Background: Epigenetic clocks have been associated with cancer risk in several observational studies. Nevertheless, it is unclear whether they play a causal role in cancer risk or if they act as a non-causal biomarker. Methods: We conducted a two-sample Mendelian randomization (MR) study to examine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fernanda Morales Berstein, Daniel L McCartney, Ake T Lu, Konstantinos K Tsilidis, Emmanouil Bouras, Philip Haycock, Kimberley Burrows, Amanda I Phipps, Daniel D Buchanan, Iona Cheng, the PRACTICAL consortium, Richard M Martin, George Davey Smith, Caroline L Relton, Steve Horvath, Riccardo E Marioni, Tom G Richardson, Rebecca C Richmond
Formato: Artigo
Lenguaje:Inglês
Publicado: eLife Sciences Publications Ltd 2022-03-01
Colección:eLife
Materias:
cancer
epigenetic age acceleration
Mendelian randomization
epigenetic clocks
epidemiology
DNA methylation
Acceso en línea:https://elifesciences.org/articles/75374
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares